Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

March 31, 2014

Conditions
Healthy
Interventions
DRUG

Valsartan 160 mg film-coated caplets (test formulation)

In each of the two study periods (separated by a washout of one week) a single dose of test or reference formulation was administered.

DRUG

Valsartan 160 mg film-coated caplets (reference formulation)

In each of the two study periods (separated by a washout of one week) a single dose of test or reference formulation was administered.

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT02518451 - Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg | Biotech Hunter | Biotech Hunter